tradingkey.logo

Entero Therapeutics Inc

ENTO
2.990USD
0.000
Close 12/24, 13:00ETQuotes delayed by 15 min
7.62MMarket Cap
LossP/E TTM

Entero Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-15.98
66.62%
Analyst Rating
--

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -15.983, with a year-on-year change of 66.62%.

What is the net income of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its net income was -18.30M, with a year-on-year change of -13.64%.

What is the net margin of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.

What is the Return on Assets (ROA) of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -33.85%, with a year-on-year change of 86.80%.

What is the operating profit of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its operating profit was -15.62M, with a year-on-year change of 0.95%.

What are the current assets of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its current assets were 83.48M, with a year-on-year change of 1584.32%.

What are the total assets of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its total assets of Entero Therapeutics Inc were 85.41M, with a year-on-year change of 1140.84%.

What are the total liabilities of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its total liabilities of Entero Therapeutics Inc were 27.61M, with a year-on-year change of 741.55%.

What is the total equity of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its total equity of Entero Therapeutics Inc was 57.80M, with a year-on-year change of 1504.37%.

What is the net operating income of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its net operating income of Entero Therapeutics Inc was -15.62M, with a year-on-year change of 1.11%.

What is the net investment of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its net investment of Entero Therapeutics Inc was 88.17K, with a year-on-year change of 117.63%.

What is the net financing of Entero Therapeutics Inc?

According to Entero Therapeutics Inc's FY2024 earnings report, its net financing of Entero Therapeutics Inc was 5.58M, with a year-on-year change of -63.35%.
KeyAI